This paper reports survey findings on the Swiss public’s willingness, attitudes, and concerns regarding personalized health research participation by providing health information and biological material. The survey reached a sample of 15,106 Swiss residents, from which we received 5,156 responses (34.1% response rate). The majority of respondents were aware of research using human biological samples (71.0%) and held a positive opinion towards this type of research (62.4%). Of all respondents, 53.6% indicated that they would be willing to participate in a personalized health research project. Willingness to participate was higher in younger, higher educated, non-religious respondents with a background in the health sector. Respondents were more willing to provide ‘traditional’ types of health data, such as health questionnaires, blood or biological samples, as opposed to social media or app-related data. All respondents valued the return of individual research results, including risk for diseases for which no treatment is available. Our findings highlight that alongside general positive attitudes towards personalized health research using data and samples, respondents have concerns about data privacy and re-use. Concerns included potential discrimination, confidentiality breaches, and misuse of data for commercial or marketing purposes. The findings of this large-scale survey can inform Swiss research institutions and assist policymakers with adjusting practices and developing policies to better meet the needs and preferences of the public. Efforts in this direction could focus on research initiatives engaging in transparent communication, education, and engagement activities, to increase public understanding and insight into data sharing activities, and ultimately strengthen personalized health research efforts.
14 September 2019 in International Journal for Equity in Health
Background: The economic crisis posed various challenges to policy-makers who had to decide on which health policy measures to focus on and on which to refrain from. The aim of this research was to assess the relevance of ethics and to highlight ethical dimensions in decision-taking by policy-makers with regard to policy and priority-setting in health systems posed by the economic crisis. Methods: Semi-structured qualitative interviews were conducted with eight European policy-makers from six countries. Results: All interviewees recalled difficult and strenuous situations where they had to prioritise between distinct areas to focus on and invest in, for example around choices between prioritising medications, health professional staffing, care specific equipment, or urgent infrastructure issues. Values could be identified which they deemed as important within the policy-making process, such as trust and responsibility. They explicitly expressed the need for ethical tools and assistance in terms of policy advice for reaching morally sustainable decisions in health policy matters. Conclusions: The study showed that ethical concepts and values frequently come into play in health policy-making, and that ethics is highly relevant in policy-makers’ daily decision-taking, yet that they lack ethical guidance on what to base their decisions. The study is of relevance since it can provide future decisions on austerity-related issues with an ethical underpinning and could identify areas of moral concern.
As donor trust legitimises research, trust is vital for research in the fields of biomedicine, genetics, translational medicine and personalised medicine. For parts of the donor community, the consent signature is a sign of trust in research. Many consent processes in biomedical research ask donors to provide their data for an unspecified future use, which introduces uncertainty of the unknown. This uncertainty can jeopardise donor trust or demand blind trust. But which donor wants to trust blindly? To reduce this uncertainty, we explore first, which future-proof actors donors could trust when signing a consent form. Second, we discuss the question Can we know if donor trust expires? and what prevents donor trust from expiring. Finally, we present possible measures that can help to nurture trust in the far future. In this article, we draw on our previous research on trust in biomedical research, on trust in the broader healthcare system and Niklas Luhmann’s and Anthony Giddens’ trust theories. Our findings suggest that, in the far future, researchers will need to consider donor autonomy, as well as societal norms and values of the time period in which the data were donated. They will need to find mechanisms where possible to publicly announce the use of old data sets. However, foremost researchers will need to treat the data respectfully. It remains vital that professionals and the society continue to elaborate on the norms and values that shape the common understanding of what is morally right and wrong when researching data.
Objectives This article aims to measure the willingness of the Swiss public to participate in personalised health research, and their preferences regarding data management and governance. Setting Results are presented from a nationwide survey of members of the Swiss public. Participants 15 106 randomly selected Swiss residents received the survey in September 2019. The response rate was 34.1% (n=5156). Respondent age ranged from 18 to 79 years, with fairly uniform spread across sex and age categories between 25 and 64 years. Primary and secondary outcome measures Willingness to participate in personalised health research and opinions regarding data management and governance. Results Most respondents preferred to be contacted and reconsented for each new project using their data (39%, 95% CI: 37.4% to 40.7%), or stated that their preference depends on the project type (29.4%, 95% CI: 27.9% to 31%). Additionally, a majority (52%, 95% CI: 50.3% to 53.8%) preferred their data or samples be stored anonymously or in coded form (43.4%, 95% CI: 41.7% to 45.1%). Of those who preferred that their data be anonymised, most also indicated a wish to be recontacted for each new project (36.8%, 95% CI: 34.5% to 39.2%); however, these preferences are in conflict. Most respondents desired to personally own their data. Finally, most Swiss respondents trust their doctors, along with researchers at universities, to protect their data. Conclusion Insight into public preference can enable Swiss biobanks and research institutions to create management and governance strategies that match the expectations and preferences of potential participants. Models allowing participants to choose how to interact with the process, while more complex, may increase individual willingness to provide data to biobanks.
Trust is increasingly recognized as a cornerstone for the successful implementation of digital public health initiatives, from mobile apps to the use of artificial intelligence in medicine, yet it remains underrepresented in educational curricula. In the course of our research and teaching activities in the field of trust in digital public health and medicine, we identified a gap in existing educational resources that aimed at supporting students in conducting structured trust analyses. Digitalization introduces new complexities into trust relationships, as interactions become increasingly mediated by digital tools. Preparing future professionals, therefore, demands fostering a critical understanding of how trust operates within digital systems, especially in the health sector. To address this gap, we developed and tested the first Trust Analysis Canvas for Teaching (TACT), a tool designed to guide students in conducting trust analyses of case studies in digital public health and medicine. Grounded in conceptual research on trust in health systems and health data sharing, we (1) developed the canvas content and reviewed it with two trust researchers; (2) tested and iteratively refined the tool with 23 students (3 BSc, 14 MSc, and 6 PhD) from diverse disciplines and academic levels through in-person and online focus groups at the universities of Zurich and Bern; (3) collaborated with a graphic designer to optimize its visual layout; and (4) translated the final canvas into French, Italian, German, and Spanish to ensure accessibility across disciplines, academic levels, and languages while maintaining a clear and engaging visual design. This paper introduces TACT, a canvas comprising 16 guiding questions organized around 6 core dimensions, designed to enable students from diverse disciplinary backgrounds and academic levels to engage with the complex concept of trust in a structured and guided manner, thereby addressing the identified gap in the current curricula. We outline the development process and provide a practical, step-by-step tutorial demonstrating its application through a written trust analysis of a digital health case study, supported by references to relevant literature.
2 November 2016 in European Journal of Public Health